Cascade Biocatalysts, Inc.
Biotechnology company · Denver, Colorado, United States
Cascade Biocatalysts, Inc. is a biotechnology company headquartered in Denver, Colorado, United States. Its earliest recorded incorporation is in 2022. It has received 1 NIH small-business research grant, $306,871 in total. It has reported private securities offerings to the US SEC, most recently $5.4 million sold in a notice filed in 2025.
Cascade Biocatalysts at a glance
What does Cascade Biocatalysts do?
US government research funding
1 NIH small-business research grant, $306,871 in total. NIH funding came from the National Center for Advancing Translational Sciences.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $5.4 million sold (2025).
Frequently asked questions about Cascade Biocatalysts
Where is Cascade Biocatalysts headquartered?
Cascade Biocatalysts, Inc. is headquartered in Denver, Colorado, United States.
What does Cascade Biocatalysts do?
Cascade Biocatalysts, Inc. is a biotechnology company.
When was Cascade Biocatalysts founded?
The earliest incorporation on record for Cascade Biocatalysts, Inc. is in 2022, according to public company registers.
Similar companies
- Vitro Biopharma, Inc.Denver, Colorado, United States
- RheumaGen, Inc.Denver, Colorado, United States
- BioCollective, LLCDenver, Colorado, United States
- BioMedInnovations LLCDenver, North Carolina, United States
- Cerecin Inc.Denver, Colorado, United States
- Op-T-Mune, IncDenver, Colorado, United States
- Rock Immune, Inc.Denver, Colorado, United States
- Ursa AnalyticsDenver, Colorado, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences